DANIEL J LEVANGIE
CIK 1187406 · EVP & President, Drug Delivery · last filed 2025-06-16
DANIEL J LEVANGIE is an EVP & President, Drug Delivery who has filed 57 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for EXAS, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$70.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.16M
7
57
-$70.14M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 34,312 | $104.91 | $3.60M | -$6.01M | 21 | 2025-06-16 |
| Renalytix plc (RNLX) Delisted | Director | — | $0.21 | — | $0 | 1 | 2023-11-22 |
| PODD | EVP & President, Drug Delivery | 21,122 | $149.70 | $3.16M | -$618.6K | 10 | 2016-05-02 |
| LIPOSCIENCE INC (LPDX) Delisted | Director | 11,122 | — | — | $41.7K | 2 | 2013-12-06 |
| ev3 Inc. (EVVV) Delisted | Director | 4,148 | — | — | $539.2K | 7 | 2010-07-13 |
| HOLOGIC INC (HOLX) Delisted | Director | 6,334 | $76.01 | $481.4K | -$17.69M | 5 | 2008-01-16 |
| CYTYC CORP (CYTC) Delisted | President, Surgical Products | 533 | — | — | -$46.40M | 9 | 2007-10-15 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,398 | $0 | EDGAR |
| 2024-12-20 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,939 | $0 | EDGAR |
| 2024-06-17 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,444 | $0 | EDGAR |
| 2024-03-04 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −5,000 | -$287.5K | EDGAR |
| 2023-11-22 | Renalytix plc (RNLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +4,678 | $0 | EDGAR |
| 2022-06-13 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,606 | $0 | EDGAR |
| 2021-07-02 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,675 | $0 | EDGAR |
| 2020-08-04 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | — | -$835.6K | EDGAR |
| 2020-07-24 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,558 | $0 | EDGAR |